Adult Services, Neuroscience

Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s

In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the treatment of patients with mild cognitive impairment (MCI) or early stages of Alzheimer’s disease. This is the first new Alzheimer’s…

Read Full Story
Adult Services, Neuroscience

Christopher P. Rhyne, M.D., headache medicine specialist, has joined Norton Neuroscience Institute

Christopher P. Rhyne, M.D., is a headache medicine specialist at Norton Neuroscience Institute. He earned his medical degree from Windsor University School of Medicine, St. Kitts, West Indies. He completed his residency in family medicine at the University of Illinois Chicago. Dr. Rhyne comes to Norton Neuroscience Institute Headache Center from the Diamond Headache Clinic…

Read Full Story
Adult Services, Neuroscience

Diagnosis and treatment for trigeminal neuralgia

The initial evaluation for trigeminal neuralgia is typically in primary care, but patients frequently also present to dental and ear, nose and throat settings, according to Brian M. Plato, D.O., a neurologist and headache specialist with Norton Neuroscience Institute. The uncommon condition is characterized by facial pain within the distribution of the trigeminal nerve. Abigail…

Read Full Story
Adult Services, Neuroscience, Spine

Shawn W. Adams, M.D., joins Norton Leatherman Spine

After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity and minimally invasive techniques. “I try to develop a relationship with my patients and partner with them to get the…

Read Full Story
Adult Services, Neuroscience, Research

Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment

Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in 3XTg mouse model demonstrated that oral administration of tributyrin mitigates age-associated loss of butyrate-producing bacteria and prevents the decline in…

Read Full Story
Adult Services, Neuroscience

Long-term multiple sclerosis treatment: Understanding prognosis, effects and therapies

Early treatment for patients with multiple sclerosis (MS) reduces the number and severity of flare-ups, delays disease progression and is associated with decreased long-term disability from neurological deficits compared with MS patients who did not begin treatment early. “Getting and staying on disease-modifying therapy is important, even when no symptoms are present, because the disease…

Read Full Story
Adult Services, Neuroscience

Adding some separation from the superior cerebellar artery relieves trigeminal neuralgia

The patient A 67-year-old woman presented to clinic with a four-year history of right-sided facial pain. After the onset of her trouble, the pain went into remission for six months. It then recurred, and she was prescribed carbamazepine. This led to significant pain relief but caused adverse changes to her mood and balance. She was…

Read Full Story
Adult Services, Neuroscience

The CND Syn-One Test can be used to confirm an initial diagnosis of Parkinson’s disease

Physicians may be able to confirm suspected Parkinson’s disease or other neurological conditions with a skin test. According to the National Institutes of Health, as many as 1 million Americans have Parkinson’s disease, and many people go undiagnosed or are misdiagnosed. This is because the symptoms of Parkinson’s disease mimic other conditions such as essential…

Read Full Story
Adult Services, Neuroscience

Alpha-synuclein skin biopsy reveals early/prodromal Parkinson’s in 61-year-old patient

The patient A 61-year-old male, who is a practicing physician, presented with concerns over his mobility raised by fellow physicians and golf partners. The patient reported that he has always been “stiff” but that perhaps he has a more shuffling gait and notices one arm is not swinging like the other when he walks. His…

Read Full Story
Adult Services, Neuroscience

Making a difference for memory care patients

Kenneth Gregory Pugh, M.D., did not choose to become a memory specialist because it was easy. He was attracted by the intellectual challenge posed by patients with complex issues. Taking the time to properly care for patients with dementia and memory issues requires evaluation, care coordination and education. Identifying and addressing issues early can make…

Read Full Story
Adult Services, Neuroscience

Keeping up with treatment and exams can postpone an MS relapse

Monitoring multiple sclerosis (MS) for treatment options through regular visits to an MS specialist can postpone relapses and improve quality of life. “MS is a complicated disease that affects each patient differently. By seeing patients regularly, we are able to reduce MS attacks or relapse and speed recovery,” said Geeta A. Ganesh, M.D., MPH, a…

Read Full Story
Adult Services, Neuroscience

Higher precision in deep brain stimulation for Parkinson’s disease

The patient A 63-year-old woman was diagnosed with Parkinson’s disease eight years earlier, after developing stiffness of the right arm and leg while undergoing treatment for breast cancer. She then developed tremor of the right thumb, and ultimately was diagnosed with Parkinson’s disease. After physical therapy did not provide adequate relief, the patient started medical…

Read Full Story